Valuation: Waldencast plc

Market Cap 13Cr 11Cr 10Cr 9.44Cr 18Cr 1.21TCr 18Cr 125.06Cr 49Cr 616.38Cr 47Cr 46Cr 1.98TCr P/E 2026 *
-2.1x
P/E 2027 * -2.39x
Enterprise Value 13Cr 11Cr 10Cr 9.44Cr 18Cr 1.21TCr 18Cr 125.06Cr 49Cr 616.38Cr 47Cr 46Cr 1.98TCr EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.39x
Free-Float
44.64%
Yield 2026 *
-
Yield 2027 * -
25/09 Waldencast Files to Delist Shares, Warrants From Nasdaq MT
21/09 Waldencast plc(NasdaqCM:WALD) added to S&P Global BMI Index CI
14/09 Top Premarket Decliners MT
14/09 Waldencast Plans Voluntary Nasdaq Delisting; Shares Down Pre-Bell MT
30/07 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, acquired Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc. CI
15/06 Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel CI
15/06 Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel MT
01/06 Waldencast plc Announces CEO Changes CI
01/06 Waldencast plc Announces Board Changes, Effective June 1, 2026 CI
01/06 Waldencast announces sale of Obagi Medical to Bridgepoint RE
01/06 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, entered into a definitive agreement to acquire Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc for $460 million. CI
15/05 Obagi Medical Shares New Data on Recent Innovations At Music City Symposium for Cosmetic Advances and Laser Education Meeting CI
14/05 Obagi Medical And Next Health Form Strategic Alliance To Launch The Skin Recharge Station Pop-Up Experience CI
1 day+10.53%
Current month-85.81%
Current year-85.81%
5 years 0.85
Extreme 0.85
10.89
10 years 0.85
Extreme 0.85
11.32
Manager TitleAgeSince
Chief Executive Officer 60 30/07/2026
General Counsel - 01/09/2023
Director TitleAgeSince
Chairman 60 01/01/2021
Director/Board Member 60 01/12/2021
Director/Board Member 52 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
+10.53%+13.18% - - 13Cr
+0.84%-0.11%-3.46%+40.46% 2.34TCr
+2.77%+2.48%-40.96%-21.04% 1.68TCr
+1.06%+1.91%-18.64% - 1.62TCr
-1.64%+0.13%-41.34%+30.33% 1.2TCr
-0.47%+0.50%+28.57% - 1.16TCr
+0.67%+1.94%-21.41%+160.29% 922.21Cr
-0.44%-0.66%-51.74%-3.25% 729.1Cr
-0.65%-2.50%+0.19%+37.22% 709.62Cr
+0.31%+3.08%+19.24%+16.12% 523.34Cr
Average +1.29%+0.60%-14.39%+37.16% 1.21TCr
Weighted average by Cap. +0.54%+0.45%-15.70%+34.04%

Financials

2026 *2027 *
Net sales 29Cr 25Cr 24Cr 22Cr 41Cr 2.76TCr 41Cr 285.92Cr 111.21Cr 1.41TCr 107.57Cr 105.26Cr 4.53TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.06TCr 45Cr 316.85Cr 123.24Cr 1.56TCr 119.2Cr 116.65Cr 5.02TCr
Net income -5.78Cr -5.13Cr -4.8Cr -4.35Cr -8.22Cr -557.24Cr -8.28Cr -58Cr -22Cr -284.27Cr -22Cr -21Cr -913.87Cr -5.18Cr -4.6Cr -4.3Cr -3.9Cr -7.37Cr -499.48Cr -7.42Cr -52Cr -20Cr -254.8Cr -19Cr -19Cr -819.14Cr
Net Debt - -
Projected Income Statement - Annual - Waldencast plc
Logo Waldencast plc
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Employees
367
Date Price Change
06/26/06 $1.050 +10.53%
05/26/05 $0.9500 +8.03%
02/26/02 $0.8794 -4.69%
01/26/01 $0.9227 +7.35%
30/26/30 $0.8595 -7.35%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Waldencast plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.050USD
Average target price
2.050USD
Spread / Average Target
+95.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Waldencast plc